Letter to dvm360: Let's talk (some more) about cannabis
To best serve veterinary patients and clients, veterinarians should be able to discuss this alternative therapeutic option.
Daniel Berkmann/stock.adobe.com
In Dr. Marc Rosenberg's recent column I was pleased to see Dr. Knox passionately and effectively defend his stance on cannabis for his veterinary patients. I was also very glad to see Dr. Rosenberg's progressive stance on the issue. As veterinarians in 2019, we need to support the need for change regarding the regulatory and legislative restraints surrounding cannabis use for veterinary (and all) patients. In order to best serve our patients, clients and the community as a whole, veterinarians need to be able to discuss and provide guidance regarding all available therapeutic options.
Elizabeth Mironchik-Frankenberg, DVM
Founder, Veterinary Cannabis Consultants
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
